FridayApr 19, 2024 12:37 pm

TinyGemsBreaks – Diamond Lake Minerals Inc. (DLMI), BOXABL Collaboration Spotlighted in Latest Proactive Interview 

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens, has been featured in an interview with Proactive. DLMI CEO Brian J. Esposito joined Proactive’s Steve Darling to discuss the company’s long-term real estate vision and its collaboration with BOXABL, Inc., a modular home building company. In the interview, Esposito stated that DLMI’s announcement and partnership with BOXABL mark a pivotal moment in expanding the use cases of BOXABL technology. DLMI and BOXABL, Esposito said, aim to identify, design and develop aesthetically pleasing communities known as Boxable Villages. Esposito…

Continue Reading

ThursdayApr 18, 2024 1:57 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Welcomes Leading Authority in Alzheimer’s Research to Scientific Advisory Board

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is announcing that Dr. David G. Morgan, PhD, a renowned leader in neurodegenerative disease, has joined its scientific advisory board (“SAB”). The announcement noted that the addition reinforces the company’s commitment to advancing its INM-901 program in the treatment of Alzheimer’s disease. Dr. Morgan is the Director of the Alzheimer’s Alliance and MSU Foundation Professor of Translational Neuroscience at Michigan State University. His research interests are Alzheimer’s disease, aging and brain function. “We are privileged to welcome someone of Dr. Morgan’s…

Continue Reading

TuesdayApr 09, 2024 3:43 pm

TinyGemsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Moves Closer to Industrialization of E-Motion(TM) Product

Vision Marine Technologies Inc. (NASDAQ: VMAR), a leader in electric marine propulsion, today announced a groundbreaking achievement in electric outboard propulsion, in collaboration with McLaren Engineering, a division of Linamar Corporation. Aligning with the fast-evolving electric market and the upcoming SAE J1228 outboard compliance standard, Vision Marine has revolutionized the measurement of rated power output with its E-Motion(TM) 180E Electric Powertrain Systems. Vision Marine and McLaren Engineering have developed a sophisticated test cell, designed to meticulously control various critical parameters and provide a comprehensive and precise assessment of the powertrain system under conditions that mimic real-world usage. “We are excited…

Continue Reading

TuesdayApr 09, 2024 2:23 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes on $3.2M Public Offering

Flora Growth (NASDAQ: FLGC), a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000-plus points of distribution around the world, has closed on an underwritten public offering. The offering, which was comprised of 1.7 million common shares, resulted in $3.23 million in gross proceeds for Flora Growth, before deductions. Flora Growth plans to use the funds from the offering for general corporate and working capital needs. Aegis Capital Corp. acted as the sole book-running manager for the offering, which closed on April 8, 2024. In addition, the company announced that its CEO, Clifford…

Continue Reading

ThursdayApr 04, 2024 3:15 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Delivers Significant Growth to Top Line Revenue

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, is celebrating its 11th anniversary of its founding in 2013 with a total of 18 contracts for new business along with five renewal agreements valued at over $1 million. “Building on the success of its first Innovation Week and the recently announced 2023 Financial Performance Highlights, Knightscope delivers significant growth to its top line revenue with these latest contracts. Fast-growing markets such as transportation, healthcare, education and local government represent the majority of these contracts and account for many more future opportunities to expand…

Continue Reading

TuesdayApr 02, 2024 3:56 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives New Epilepsy, Anti-Viral Agent Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received three new patent awards. According to the announcement, the company was awarded two new patents in its epilepsy patent family; both awards were granted in the United States. The U.S. patents, which cover both swallowed capsules and dissolvable oral tablets, complement research indicating DehydraTECH-CBD has potential to decrease epileptic seizures in rodents and to be absorbed into the bloodstream more effectively than the current treatments. In addition, Lexaria was awarded a patent in Japan in is antiviral agent patent family. The new patents bring the total of…

Continue Reading

TuesdayApr 02, 2024 3:14 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Enters Acquisition Agreement to Acquire Biodefense Vaccine Developer

Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, has signed a definitive arrangement agreement to acquire Appili Therapeutics Inc. (TSX: APLI) (OTCQX: APLIF). Appili is a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures. According to the agreement, Adivir Inc., a wholly owned subsidiary of Aditxt, will acquire all issued and outstanding Class A common shares of Appili. Assets acquired by Aditxt will include FDA-approved LIKMEZ(TM), which is the ATI-1701 tularemia vaccine defense program, and the ATI-1801 topical formulation. “The acquisition of Appili would represent another step in Aditxt’s journey towards…

Continue Reading

MondayApr 01, 2024 3:57 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces FTZ Filing as ‘Strategic Initiative’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has filed for Foreign Trade Zone (“FTZ”) status with the U.S. Department of Commerce; the company is filing for the status at its commercial vehicle manufacturing and assembly center in Tunica, Mississippi. According to the announcement, the company anticipates that FTZ status would provide key benefits, including the opportunity for improving company cash flow through reduction of taxes, fees and deferment of import duties. Specifically, Mullen projects that deferred working capital on domestic sales could result in deferred capital outlays of $10 million for the remainder of fiscal year 2024.…

Continue Reading

MondayApr 01, 2024 3:44 pm

TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, FY 2023 Financial Report, Operational Update

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is reporting financial results and operating highlights for Q4 and full year 2023, for the period ended Dec. 31, 2023. The report noted that revenue came in at $3.2 million for Q4 2023 and $13.8 million for the full year; gross profit was $2.1 million for the Q4 2023 and $8.3 million for the full year; and gross margin totaled 64% for Q4 2023 and 60% for the full year. In addition, the company reported…

Continue Reading

MondayApr 01, 2024 3:26 pm

TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Releases Year-End 2023 Financial Report, Business Update

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial-intelligence (“AI”) and machine-learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, is reporting on its financial and operating results for the year ended Dec. 31, 2023; the company also released a corporate update. The report noted POAI experienced a net loss of some $14 million on total revenue of approximately $1.8 million for the year; the company also reported a 50% reduction in basic and diluted net loss per common share for the full year 2023. In…

Continue Reading

Contact us: (310) 299-1717